Project Grant K22AI184586
- Federal Project Grant Award Summary The University of Pittsburgh received a $556,843 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 16, 2025, with a completion date of June 30, 2030. This grant supports basic immunology research investigating the development and regulation of the extrafollicular (EF) B cell response as a programmed immune response type. The research aims...
- Federal Grant Award Summary The University of Pittsburgh received a $641,889 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the project "Developing a Molecular Taxonomy for Immune-Mediated Diseases," effective April 1, 2026 through March 31, 2031. The award funds research to develop precision biomarkers and machine learning tools that enable classification of...
- Federal Grant Award Summary The University of Pittsburgh received a $1.455 million Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 3, 2025, with completion targeted for May 31, 2030. This award supports innovative immunological research designed to extend kidney allograft survival and enable immunosuppressive drug withdrawal in nonhuman primates (rhesus macaques). The...
- Federal Project Grant Award Summary The University of Pittsburgh received a $452,835 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 2, 2026, with a completion date of January 31, 2028. This award supports investigator-initiated research focused on reversing graft rejection in transplant recipients by targeting innate immune memory with novel nanobiologic...
- Federal Project Grant Award Summary The University of Pittsburgh received a $437,250 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on February 23, 2026, with a completion date of January 31, 2028. The award funds research and development of a novel skin immunization platform (SIP) designed to improve the immunogenicity and efficacy of subunit vaccines. The project delivers...
- Federal Grant Award Summary The University of Pittsburgh received a $762,086 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective April 1, 2026, through March 31, 2031. This five-year award supports the development and application of mass spectrometry proteomics tools to characterize protein abundance and phosphorylation patterns in pathogenic T helper 17 (TH17) cells. The research...
- Federal Grant Award Summary The University of Pittsburgh received a $135,586 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period April 1, 2026 through March 31, 2028. The project, titled "Generation of a Non-Cleavable Allele of PIK3IP1/TRIP," supports basic immunological research aimed at understanding the regulatory mechanisms of phosphoinositide 3-kinase...
- Federal Grant Award Summary The University of Pittsburgh received a $437,250 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 25, 2025, with completion targeted for June 30, 2027. This award supports research targeting host nuclear receptors for the resolution of Methicillin-Resistant Staphylococcus aureus (MRSA) skin and soft tissue infections (SSTIs). The research aims...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Pittsburgh a Project Grant totaling $599,433 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period May 1, 2025 through April 30, 2027. This research project investigates B cell central tolerance to a model commensal antigen, focusing on how the immune system establishes and maintains homeostasis with commensal microbes while preserving...
- Federal Project Grant Award Summary The University of Pittsburgh received a $634,981 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on June 17, 2025, with a completion date of May 31, 2030. This award supports research investigating the role of Merkel Cell Polyomavirus (MCV) small T antigen in persistent viral infection and its relationship to Merkel Cell Carcinoma development....
The University of Pittsburgh received a $162,000 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period April 1, 2026, through March 31, 2028. The award supports investigator-initiated biomedical research examining how environmental stress-induced adaptive immune responses impact tissue physiology and tumorigenesis. The research focuses on understanding the recruitment, retention, and functional mechanisms of endogenous retroelement-specific CD8 T cells in skin tissue following environmental stressors such as detergent exposure, with particular attention to how these immune responses promote wound repair and may contribute to tumor development. The research employs three mouse model systems—parabiosis, flank punch biopsy, and transplantable cutaneous melanoma—to investigate the molecular and cellular mechanisms underlying stress-induced immune responses in skin. The project addresses significant public health concerns, including the estimated 6.5 million Americans suffering from chronic non-healing skin wounds and the high prevalence of skin cancer in the United States. By elucidating the relationship between environmental exposure, immune cell biology, and tissue repair versus tumorigenesis pathways, this research is intended to generate scientific knowledge that may inform therapeutic approaches to both wound healing and cancer prevention.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $162.0k | 4/1/26 |